Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksModel.php on line 57

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Settings.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Keyphrases.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Statistics.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Modules.php on line 16
alimta pemetrexed mesothelioma



Eli Lilly & Co Data Affirm Benefit Of Alimta (Nasdaq)

LONDON -(Dow Jones)- Eli Lily said Wednesday that data from two large, open- label studies show patients experienced one-year survival rates above 50 percent when treated with ALIMTA® (pemetrexed for injection) or ALIMTA-based regimens for malignant pleural mesothelioma (MPM) in both a first-line and second-line setting.

More: continued here




   Posted in mesothelioma    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.






Leave a Reply